Anupam Rasayan India Ltd Share Price Today

Anupam Rasayan India Ltd Share Price

Overview

Anupam Rasayan India Ltd share price is currently ₹1,224.31, down by - ₹8.07 (0.65%) from its previous closing price of ₹1,232.38. The share price has gained 1.9% over the past month and gained 10.17% over the past year. The stock's 52-week low and high are ₹1,025.99 and ₹1,391.52, respectively. Anupam Rasayan India Ltd has a market capitalisation of ₹ 14,350.00 Cr. The share price was last updated on 04 Sep 2026, 03:30 PM IST.

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 7.5% at ₹0.75/Share	21-Jul-2025	21-Jul-2025
DividendsFinal Dividend of 7.5% at ₹0.75/Share	17-Sep-2024	18-Sep-2024

Actions

Ex-Date

Record-Date

DividendsInterim Dividend of 7.5% at ₹0.75/Share

21-Jul-2025

DividendsFinal Dividend of 7.5% at ₹0.75/Share

17-Sep-2024

18-Sep-2024

Mutual Fund Holder	Jul 26 Shares held	Aug 26 Shares held
UTI Nifty 500 Index Fund - Regular Plan - Growth	-	167 (100%)
UTI Nifty 500 ETF	-	13 (100%)
Zerodha Nifty MidSmallcap400 50:50 Index Fund - Growth - Direct Plan	92	- (100%)
SBI Nifty Smallcap 250 Index Fund - Regular Plan - Growth	24.27 k	- (100%)
SBI Nifty Smallcap 250 ETF	110	- (100%)

Mutual Fund Holder

Jul 26

Shares held

Aug 26

Shares held

UTI Nifty 500 Index Fund - Regular Plan - Growth

167

(100%)

UTI Nifty 500 ETF

(100%)

Zerodha Nifty MidSmallcap400 50:50 Index Fund - Growth - Direct Plan

(100%)

SBI Nifty Smallcap 250 Index Fund - Regular Plan - Growth

24.27 k

(100%)

SBI Nifty Smallcap 250 ETF

110

(100%)

CA Sumit Mangla

14 Aug • 8:56 PM · SEBI-Registered Analyst

Anupam Rasayan Q1 Net Profit Rises 14% to ₹38.7 Cr; EBITDA Up 31% YoY

ANURAS

India reported consolidated net profit of ₹387 million for Q1, up from ₹340 million year-on-year. EBITDA rose to ₹1.62 billion from ₹1.24 billion, a 31% increase, while EBITDA margin moderated slightly to 24.8% from 25.6%. The results reflect continued growth in the specialty chemicals and custom synthesis business amid a strong operational performance. Top stocks in the specialty chemicals industry: Vinati Organics, Aarti Industries, and Navin Fluorine International.

Sunil Kotak

14 Aug • 12:45 PM · SEBI-Registered Analyst

Q1FY27 Quarterly Result Announced for Anupam Rasayan India Ltd.

ANURAS

SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Specialty Chemicals company Anupam Rasayan India announced Q1FY27 results Consolidated Financial Highlights: Revenue from Operations for Q1FY27 was Rs 6,549.80 million, representing a YoY increase of 34.82% from Rs 4,858.27 million in Q1FY26 and a QoQ growth of 3.02% from Rs 6,357.83 million in Q4FY26. Total Revenue stood at Rs 6,675.45 million in Q1FY27, up 36.03% YoY compared to Rs 4,907.39 million in Q1FY26 and 4.44% higher on a QoQ basis from Rs 6,391.52 million in Q4FY26. Profit Before Tax (PBT) reached Rs 696.81 million in Q1FY27, showing a YoY growth of 10.87% from Rs 628.50 million in Q1FY26 and a QoQ increase of 24.28% from Rs 560.68 million in Q4FY26. Profit after tax for the Period was Rs 512.15 million in Q1FY27, up 5.69% YoY from Rs 484.58 million in Q1FY26, but decreased by 8.54% QoQ from Rs 559.96 million in Q4FY26. Basic Earnings Per Equity Share (EPS) for Q1FY27 was Rs 3.39 compared to Rs 3.10 in Q1FY26 and Rs 3.75 in Q4FY26. All this is for information This is not a buy/sell recommendation. Thank you, Technofunda24

Harika Enjamuri

15 Jul • 3:41 PM · SEBI-Registered Analyst

Anupam Rasayan Signs Potential ₹2,885 Crore Pact to Expand in Next-Generation Battery Chemicals

Anupam Rasayan India Ltd. has taken another strategic step in the advanced chemicals space by signing a non-binding Letter of Intent (LoI) with Spain-based BASQUEVOLT S.A. to explore the long-term supply of a speciality chemical used in solid-state battery applications. The proposed engagement has the potential to generate cumulative revenue of approximately ₹2,885 crore (around $300 million) over a period of up to 10 years, although commercial supplies will depend on the successful completion of product development and the execution of a final supply agreement. BASQUEVOLT develops solid-state lithium batteries for electric vehicles, heavy transport, renewable energy storage and aviation, making this collaboration a significant opportunity for Anupam Rasayan to strengthen its presence in the fast-growing electronic chemicals segment. The company believes this aligns with its long-term strategy of expanding into technology-driven industries through continuous investments in research and development, process capabilities and innovation. Currently, Anupam Rasayan serves more than 75 domestic and international customers, including 31 multinational companies, and operates six manufacturing facilities in Gujarat, highlighting its strong manufacturing base and growing global presence in speciality chemicals.

ANURAS

Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

CA Barkha Kamra

15 Jul • 12:21 PM · SEBI-Registered Analyst

Anupam Rasayan India Ltd

* Strategic EV battery chemicals deal:

ANURAS

has signed a Letter of Intent (LoI) with Basquevolt S.A. for the potential long-term supply of a specialty chemical product valued at ~US$300 million (≈₹2,550 crore), strengthening its presence in the fast-growing EV battery materials value chain. * Scale & impact: The proposed contract is one of the company’s largest announced opportunities and enhances long-term revenue visibility. Anupam Rasayan’s market capitalisation is around ₹14,400 crore.

Kundan Motwani

15 Jul • 11:19 AM · SEBI-Registered Analyst

ANURAS

ANUPAM RASAYAN: SIGNS LETTER OF INTENT WITH BASQUEVOLT, S.A. FOR THE POTENTIAL LONG-TERM SUPPLY OF A SPECIALTY CHEMICAL PRODUCT WORTH $300M

Sneha M Vasudeo

12 Jun • 12:29 PM · SEBI-Registered Analyst

My View: Top 3 Developments to Watch

ANURAS

– Global First Commercialisation of ETFA Becoming the first company globally to commercialise ETFA using flow chemistry is a significant technological milestone. This could strengthen Anupam Rasayan's position in high-value specialty chemicals and create opportunities for long-term revenue growth. Investors should monitor commercial-scale production, customer adoption, and margin expansion. 2.

SAGILITY

– Acquisition of CareSeed The acquisition expands Sagility's healthcare analytics capabilities and deepens its presence in the US healthcare market. The deal could enhance cross-selling opportunities and strengthen the company's end-to-end healthcare solutions portfolio. Key factors to watch include integration execution and the contribution to earnings growth. 3.

TATAPOWER

– Approval to Recover Higher Power Purchase Costs DERC's approval allows distribution companies to recover higher power procurement costs incurred during April 2026. This may help reduce financial pressure on Tata Power's distribution business and support cash flows. Investors should watch for the impact on future earnings and regulatory developments in the power sector. For educational purposes only. Not investment advice.

Anupam Rasayan India Ltd Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Anupam Rasayan India Ltd 👋

Expert Opinions

News & Events

Frequently Asked Questions

What is the share price of Anupam Rasayan India Ltd?

What is the market cap of Anupam Rasayan India Ltd?

Should I buy Anupam Rasayan India Ltd stock now?

What is the 52 week high and low of Anupam Rasayan India Ltd?

Is the Anupam Rasayan India Ltd stock good to buy?

Is Anupam Rasayan India Ltd a good buy for the long term?

Is Anupam Rasayan India Ltd overvalued or undervalued?

What is the PE and PB ratio of Anupam Rasayan India Ltd?